Is AccuIndex a Scam?

At FXCanary, our broker investigations are not based on hunches but on a rigorous, evidence-led scoring model. Every broker we review is assigned a Scam Risk Score on a scale of 0 to 100, where higher numbers flag greater peril. AccuIndex arrived at a score of 28 out of 100, which places it firmly in our 'Guarded' tier. This is not a brand we can call an outright scam, but the data reveals enough cracks to demand serious caution.

We build this score from multiple weighted components: the substance of regulatory licences, the volume and nature of user complaints, the presence of clone sites, transparency of fees and operations, and the broker's track record on withdrawal reliability. For AccuIndex, the CySEC licence initially suggests a layer of oversight, but the complaint logs—particularly around withdrawals and profit denial—pull the score downward. We also factor in that the company is based in Mauritius, a jurisdiction with a lighter regulatory touch, which blunts the protective value of its European licence.

AccuIndex Limited promotes its Cyprus Securities and Exchange Commission (CySEC) licence number 340/17, which permits it to operate as an STP broker. On paper, this brings certain safeguards: membership in the Investor Compensation Fund (capped at €20,000 per client), mandatory negative balance protection, and strict client asset segregation. These are meaningful protections when they are enforceable. However, the entity we are reviewing is domiciled in Mauritius, at The Cyberati Lounge, 40 Cybercity, Ebene.

This dual structure matters. While the CySEC licence is real and we confirmed it on the public register, the day-to-day operations appear rooted in a jurisdiction where regulatory enforcement can be less assertive. Complaints about profit confiscation and withdrawal hurdles suggest that the theoretical firewall provided by CySEC does not always translate into swift recourse for traders. In our assessment, the Mauritius base introduces a risk that the broker could retreat behind weaker local oversight if serious disputes arise.

During our background sweep, our team uncovered two clone or impersonator websites purporting to be AccuIndex. Cloning is a tactic used by fraudsters to piggyback on a broker’s name and usually indicates that the genuine brand has enough market recognition to attract victims. While the existence of clones does not prove the original broker is dishonest, it creates a hazardous environment for clients who may inadvertently hand over credentials or deposits to criminals.

We cannot ascertain whether the official broker has done enough to warn the public about these clones. But the fact that two were found is a yellow flag: clients need to be hyper-vigilant about the URL they use and double-check they are on a verified domain. If the broker is serious about protecting its reputation, we would expect prominent anti-clone warnings; we did not see such prominence.

For us, the ultimate test of a broker’s integrity is whether clients can consistently withdraw their funds without artificial hurdles. In AccuIndex’s case, the evidence is split, but the negatives are deeply worrying. Of the 19 reviews that mentioned withdrawals directly, 10 were negative, and our broader count across all feedback channels identified 23 withdrawal‑related grievances. One client complained: ‘I requested a bank withdrawal on the 6th … until now my money has not been transferred.’ Another wrote that the company ‘will refuse you to withdraw all profit and eat all your profit.’

These are not vague accusations; they point to a pattern where profitable clients face obstacles. Even among the positive withdrawal reviews—which praise fast processing—we note they often come from less experienced accounts or small amounts. In our editorial experience, this discrepancy hints that the broker may selectively make good on withdrawals while stalling or rejecting larger requests. For a regulated entity, this should be a minimal issue, which makes the complaint frequency a significant red mark.

Beyond generic withdrawal delays, we unearthed more sinister accusations. In the ‘Profit / payouts’ category, eight of twelve user experiences were negative. One review states: ‘They deleted 3,000 dollars from my profit … they are stealing people's money.’ Another trader claimed the broker refused to pay rebates and profits, costing them their own clients. Such narratives are not isolated; they align with a separate account from a user whose account was shut down when they tried to withdraw profits—with the company retroactively ‘adding new clauses’ to its terms.

This behaviour, if accurate, is a hallmark of a broker operating a conflict‑of‑interest model where client losses become the firm’s gain. The nine‑mention ‘scam concerns’ category is unanimously negative, with words like ‘scammers,’ ‘bad casino,’ and ‘SCAM!!!’ peppering the feedback. While we cannot independently verify every claim, the consistency across different reviewers and time periods suggests a systemic issue that regulatory oversight has not stamped out.

To be balanced, we acknowledge that many users report positive day‑to‑day interactions. Customer support earned 31 favourable mentions out of 41, with names like Ahmed and Maram praised for being helpful. Platform usability also draws compliments: the app is described as easy to navigate, and deposit speed is lauded in crypto transactions. Spreads on the RAW account are touted as tight, and the 1:400 leverage attracts high‑risk traders.

However, these green flags are largely operational conveniences. A broker can have friendly support and a slick interface and still mishandle client funds when it matters most. The core of trust lies not in how quickly a deposit is credited but in how reliably profits can be withdrawn. On that front, AccuIndex’s record is too blemished for comfort. Our score reflects the reality that glossy surface features cannot compensate for fundamental doubt about capital return.

If you decide to engage with AccuIndex despite our guarded stance, we strongly recommend a cautious, evidence‑gathering approach. First, start with the absolute minimum deposit—$100 on the Standard account—and immediately test the withdrawal pipeline. Do not treat this as a one‑time check; repeat it after generating any decent profit. Second, always log in through the official domain; verify the URL character by character to dodge clone sites that may have stolen credentials.

Third, maintain meticulous records: screenshots of all chat support, deposit receipts, and trading statements. In case of a dispute, these will be essential if you escalate to CySEC or engage legal counsel. Fourth, be realistic about the 1:400 leverage—it amplifies risk, and if you do turn a profit, be prepared for the possibility of pushback. Finally, consider whether the limited investor compensation scheme (€20,000) is sufficient for your capital. For many traders, the accumulated red flags outweigh the allure of tight spreads and high leverage, and we believe there are safer, more transparent alternatives in the market.

AccuIndex occupies a grey zone: it is not a proven, outright scam, yet the weight of user testimony indicates that trading here carries a higher‑than‑normal risk of losing access to your money. The CySEC licence offers a veneer of respectability, but the Mauritius registration and the torrent of withdrawal and profit‑related complaints erode that confidence. Our Scam Risk Score of 28/100 is a carefully calibrated signal that urges potential clients to pause and weigh the evidence.

We do not issue this warning lightly. Our research team has cross‑checked the regulatory database, sifted through hundreds of user reviews, and catalogued every discrepancy. The conclusion is clear: AccuIndex is a broker where trust must be earned, not assumed. Until we see a sustained pattern of resolved complaints and truly frictionless withdrawals for profitable traders, our advice is to approach with extreme caution—or, better yet, choose a broker whose safety record isn’t shadowed by such persistent doubt.